Literature DB >> 5333306

Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects.

P Donnelly, K Lloyd, H Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5333306      PMCID： PMC1840398          DOI： 10.1136/bmj.1.5532.69

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  20 in total

1.  INDOMETHACIN IN RHEUMATIC DISEASES. A CONTROLLED CLINICAL TRIAL.

Authors:  J WANKA; L I JONES; P H WOOD; A S DIXON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  INDOMETHACIN IN THE TREATMENT OF RHEUMATIC DISEASES.

Authors:  J S PERCY; P STEPHENSON; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

3.  INDOMETHACIN, REMARKABLE ANTIRHEUMATIC DRUG.

Authors:  M KELLY
Journal:  Med J Aust       Date:  1964-10-03       Impact factor: 7.738

4.  [CLINICAL AND METABOLIC EFFECTS OF INDOMETHACIN IN RHEUMATIC DISEASES].

Authors:  C B BALLABIO; G GIRARDI; I CARUSO; E CIRLA; B COLOMBO
Journal:  Reumatismo       Date:  1963 Nov-Dec

5.  CLINICAL TEST OF INDOMETHACIN.

Authors:  L J MICHOTTE; M WAUTERS
Journal:  Acta Rheumatol Scand       Date:  1964

6.  [CURRENT PROBLEMS OF DRUG THERAPY OF RHEUMATISM].

Authors:  K MIEHLKE
Journal:  Munch Med Wochenschr       Date:  1965-01-01

7.  THE EFFECTS OF INDOMETHACIN ON RHEUMATIC FEVER.

Authors:  A VIGNAU; E CORREA; J GUASCH; A SCHUSTER; A PATRI; S VAISMAN; E A MORTIMER
Journal:  Arthritis Rheum       Date:  1965-08

8.  Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors:  J LANSBURY
Journal:  Arthritis Rheum       Date:  1958-12

9.  Indomethacin in rheumatoid arthritis. A comparative objective evaluation with adrenocorticosteroids.

Authors:  C J Smyth
Journal:  Arthritis Rheum       Date:  1965-10

10.  Indomethacin in ankylosing spondylitis.

Authors:  E Kåss
Journal:  Acta Rheumatol Scand       Date:  1965
View more
  9 in total

1.  The effect of buffered aspirin on plasma indomethacin.

Authors:  J C Garnham; K Raymond; E Shotton; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

2.  Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.

Authors:  H F Hill; A G Hill; A G Mowat; B M Ansell; J A Mathews; M H Seifert; J M Gumpel; G A Christie
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

3.  Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

Authors:  G Nuki; W W Downie; W C Dick; K Whaley; J B Spooner; M A Darby-Dowman; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

4.  Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.

Authors:  R M Mason; D E Barnardo; W R Fox; M Weatherall
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

5.  Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines.

Authors:  Yvonne Nestoriuc; E John Orav; Matthew H Liang; Robert Horne; Arthur J Barsky
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

6.  Indomethacin serum concentrations in man. Effects of dosage, food, and antacid.

Authors:  H W Emori; H Paulus; R Bluestone; G D Champion; C Pearson
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

7.  Indomethacin in the treatment of rheumatoid arthritis. A controlled trial comparing indomethacin, phenylbutazone, and placebo.

Authors:  V Wright; W C Walker; R J McGuire
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

8.  Double-blind dose-response study of indomethacin in rheumatoid arthritis.

Authors:  R Ekstrand; G Alván; M L'e Orme; R Lewander; L Palmér; B Sarby
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

9.  An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients.

Authors:  Rajan Ravichandran; Surapaneni Krishna Mohan; Suresh Kumar Sukumaran; Devakumar Kamaraj; Sumetha Suga Daivasuga; Samson Oliver Abraham Samuel Ravi; Sivakumar Vijayaraghavalu; Ramarathnam Krishna Kumar
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.